200,000+ products from a single source!
sales@angenechem.com
Home > Other Building Blocks > 13623-87-5
13623-87-5 | 1,2,3,4-Tetrahydro-1,8-naphthyridine
CAS No: 13623-87-5 Catalog No: AG003D9W MDL No:MFCD08234598
Product Description
Catalog Number:
AG003D9W
Chemical Name:
1,2,3,4-Tetrahydro-1,8-naphthyridine
CAS Number:
13623-87-5
Molecular Formula:
C8H10N2
Molecular Weight:
134.1784
MDL Number:
MFCD08234598
IUPAC Name:
1,2,3,4-tetrahydro-1,8-naphthyridine
InChI:
InChI=1S/C8H10N2/c1-3-7-4-2-6-10-8(7)9-5-1/h1,3,5H,2,4,6H2,(H,9,10)
InChI Key:
ZCZVGQCBSJLDDS-UHFFFAOYSA-N
SMILES:
C1CNc2c(C1)cccn2
Properties
Complexity:
114
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
134.084g/mol
Formal Charge:
0
Heavy Atom Count:
10
Hydrogen Bond Acceptor Count:
2
Hydrogen Bond Donor Count:
1
Isotope Atom Count:
0
Molecular Weight:
134.182g/mol
Monoisotopic Mass:
134.084g/mol
Rotatable Bond Count:
0
Topological Polar Surface Area:
24.9A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
1.6
Literature
| Title | Journal |
|---|---|
| Dihydro-pyrano[2,3-b]pyridines and tetrahydro-1,8-naphthyridines as CB1 receptor inverse agonists: synthesis, SAR and biological evaluation. | Bioorganic & medicinal chemistry letters 20100615 |
| Methods for the synthesis of 5,6,7,8-tetrahydro-1,8-naphthyridine fragments for alphaVbeta3 integrin antagonists. | The Journal of organic chemistry 20041210 |
| Nonpeptide alpha V beta 3 antagonists. Part 10: In vitro and in vivo evaluation of a potent 7-methyl substituted tetrahydro-[1,8]naphthyridine derivative. | Bioorganic & medicinal chemistry letters 20040906 |
| Non-peptide alpha v beta 3 antagonists. Part 7: 3-Substituted tetrahydro-naphthyridine derivatives. | Bioorganic & medicinal chemistry letters 20040223 |
| Identification of oxidative degradates of the TRIS salt of a 5,6,7,8-tetrahydro-1,8-naphthyridine derivative by LC/MS/MS and NMR spectroscopy--interactions between the active pharmaceutical ingredient and its counterion. | Journal of pharmaceutical and biomedical analysis 20031204 |
| Cascade cyclizations via N,4-didehydro-2-(phenylamino)pyridine biradicals/zwitterions generated from enyne-carbodiimides. | The Journal of organic chemistry 20030711 |
| Nonpeptide alpha(v)beta(3) antagonists. Part 2: constrained glycyl amides derived from the RGD tripeptide. | Bioorganic & medicinal chemistry letters 20020107 |
Related Products
Featured Products
© 2019 Angene International Limited. All rights Reserved.